Eamon Comer
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Molecular Biology top 5%
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- Histone Deacetylase Inhibitors Research
- Chemical Synthesis and Analysis
Papers in ⓘ
-
- Chemical Synthesis and Analysis 8
- Protein Degradation and Inhibitors 3
- RNA and protein synthesis mechanisms 3
-
- Synthesis and Catalytic Reactions 3
- Co-authors
- Michael G. Organ (3 shared papers)Stuart L. Schreiber (12 shared papers)Monica Schenone (4 shared papers)Steven A. Carr (4 shared papers)Christie Ciarlo (4 shared papers)Benjamin L. Ebert (3 shared papers)Tanya Svinkina (2 shared papers)Nikhil C. Munshi (1 shared paper)
- Journals
- Journal of the American Chemical Society (3 papers)ACS Infectious Diseases (3 papers)Nature Communications (2 papers)Future Medicinal Chemistry (2 papers)Blood (2 papers)
- Partner nations
- United StatesIndiaUnited Kingdom
In The Last Decade
Eamon Comer
27 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Hematology 586
- Molecular Biology 1.4k
- Organic Chemistry 591
- Oncology 437
- Immunology 173
Countries citing papers authored by Eamon Comer
This map shows the geographic impact of Eamon Comer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eamon Comer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eamon Comer more than expected).
Fields of papers citing papers by Eamon Comer
This network shows the impact of papers produced by Eamon Comer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eamon Comer. The network helps show where Eamon Comer may publish in the future.
Co-authors
The 25 scholars most cited alongside Eamon Comer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells Hit paper breakdown → | 2013 | 1288 |
| 2 | 2005 | 208 | |
| 3 | 2015 | 110 | |
| 4 | 2007 | 106 | |
| 5 | 2017 | 105 | |
| 6 | 2005 | 82 | |
| 7 | 2016 | 55 | |
| 8 | 2018 | 39 | |
| 9 | 1993 | 35 | |
| 10 | 2015 | 30 | |
| 11 | 2015 | 28 | |
| 12 | 2011 | 27 | |
| 13 | 2021 | 26 | |
| 14 | 2023 | 23 | |
| 15 | 2011 | 20 | |
| 16 | 2014 | 19 | |
| 17 | 2012 | 19 | |
| 18 | 2022 | 17 | |
| 19 | 2004 | 14 | |
| 20 | 2003 | 13 |
About Eamon Comer
Eamon Comer is a scholar working on Molecular Biology, Organic Chemistry, Epidemiology, Public Health, Environmental and Occupational Health and Computational Theory and Mathematics, having authored 27 papers that have together received 2.3k indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (8 papers), Computational Drug Discovery Methods (4 papers), Malaria Research and Control (4 papers), Protein Degradation and Inhibitors (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers), RNA and protein synthesis mechanisms (3 papers), Synthesis and Catalytic Reactions (3 papers) and Toxoplasma gondii Research Studies (3 papers). The work is most often cited by research in Hematology (586 citations), Molecular Biology (1.4k citations), Organic Chemistry (591 citations), Oncology (437 citations) and Immunology (173 citations). Eamon Comer has collaborated with scholars based in United States, India and United Kingdom. Frequent co-authors include Michael G. Organ, Stuart L. Schreiber, Monica Schenone, Steven A. Carr, Christie Ciarlo, Benjamin L. Ebert, Tanya Svinkina, Nikhil C. Munshi, Peter Grauman and Emily C. Hartman. Their work appears in journals such as Journal of the American Chemical Society, ACS Infectious Diseases, Nature Communications, Future Medicinal Chemistry and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.